Array
(
[id] => 2099
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular
assessment and management of patients
undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/2099.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.116
[inputtime] => 2024-12-19 09:42:40
[updatetime] => 2024-12-19 09:42:40
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with a family history of genetic cardiomyopathy, it is recommended to perform an ECG and TTE before NCS, regardless of age and symptoms.(Evidence: Level C,Recommendation: Class Ⅰ)
[laiyuan] => 推荐有遗传心肌病家族史的患者,无论年龄和症状,在NCS术前均应检查心电图(ECG)和超声心动图( UCG)。(证据级别:C;推荐强度:I)
[znzldj] => A
[_inputtime] => 1734572560
[_updatetime] => 1734572560
[_nrjc] =>
[_nrsh] =>
)
推荐意见
推荐有遗传心肌病家族史的患者,无论年龄和症状,在NCS术前均应检查心电图(ECG)和超声心动图( UCG)。(证据级别:C;推荐强度:I)
In patients with a family history of genetic cardiomyopathy, it is recommended to perform an ECG and TTE before NCS, regardless of age and symptoms.(Evidence: Level C,Recommendation: Class Ⅰ)
证据评价方法:LOE
指南质量等级:A
年份:2022
国家:the European Society of Anaesthesiology and Intens
Array
(
[id] => 2100
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular
assessment and management of patients
undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/2100.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.116
[inputtime] => 2024-12-19 09:42:40
[updatetime] => 2024-12-19 09:42:40
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients aged 45–65 years without signs,symptoms, or history of CVD, ECG and biomarkers should be considered before high-risk NCS.(Evidence: Level C,Recommendation: Class IIa)
[laiyuan] => 45~65岁没有CVD症状、体征或病史的患者,在高风险NCS 术前应检查 ECG 和生物标志物。(证据级别:C;推荐强度:IIa)
[znzldj] => A
[_inputtime] => 1734572560
[_updatetime] => 1734572560
[_nrjc] =>
[_nrsh] =>
)
推荐意见
45~65岁没有CVD症状、体征或病史的患者,在高风险NCS 术前应检查 ECG 和生物标志物。(证据级别:C;推荐强度:IIa)
In patients aged 45–65 years without signs,symptoms, or history of CVD, ECG and biomarkers should be considered before high-risk NCS.(Evidence: Level C,Recommendation: Class IIa)
证据评价方法:LOE
指南质量等级:A
年份:2022
国家:the European Society of Anaesthesiology and Intens
Array
(
[id] => 2101
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular
assessment and management of patients
undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/2101.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.116
[inputtime] => 2024-12-19 09:42:40
[updatetime] => 2024-12-19 09:42:40
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with a newly detected murmur and symptoms or signs of CVD, TTE is recommended before NCS.(Evidence: Level C,Recommendation: Class Ⅰ)
[laiyuan] => 新发现CVD的心脏杂音、症状或体征的患者推荐NCS 术前检查 UCG。(证据级别:C;推荐强度:I)
[znzldj] => A
[_inputtime] => 1734572560
[_updatetime] => 1734572560
[_nrjc] =>
[_nrsh] =>
)
推荐意见
新发现CVD的心脏杂音、症状或体征的患者推荐NCS 术前检查 UCG。(证据级别:C;推荐强度:I)
In patients with a newly detected murmur and symptoms or signs of CVD, TTE is recommended before NCS.(Evidence: Level C,Recommendation: Class Ⅰ)
证据评价方法:LOE
指南质量等级:A
年份:2022
国家:the European Society of Anaesthesiology and Intens
Array
(
[id] => 2102
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular
assessment and management of patients
undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/2102.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.116
[inputtime] => 2024-12-19 09:42:40
[updatetime] => 2024-12-19 09:42:40
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with a newly detected murmur suggesting clinically significant pathology, TTE is recommended before high-risk NCS.(Evidence: Level C,Recommendation: Class Ⅰ)
[laiyuan] => 新发现有临床显著病理性杂音的患者,推荐在高风险NCS术前检查UCG。(证据级别:C;推荐强度:I)
[znzldj] => A
[_inputtime] => 1734572560
[_updatetime] => 1734572560
[_nrjc] =>
[_nrsh] =>
)
推荐意见
新发现有临床显著病理性杂音的患者,推荐在高风险NCS术前检查UCG。(证据级别:C;推荐强度:I)
In patients with a newly detected murmur suggesting clinically significant pathology, TTE is recommended before high-risk NCS.(Evidence: Level C,Recommendation: Class Ⅰ)
证据评价方法:LOE
指南质量等级:A
年份:2022
国家:the European Society of Anaesthesiology and Intens
Array
(
[id] => 2103
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular
assessment and management of patients
undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/2103.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.116
[inputtime] => 2024-12-19 09:42:40
[updatetime] => 2024-12-19 09:42:40
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with a newly detected murmur, but without other signs or symptoms of CVD, TTE should be considered before moderate-risk NCS.(Evidence: Level C,Recommendation: Class IIa)
[laiyuan] => 新发现杂音、但没有其他CVD症状或体征的患者,推荐在中高风险NCS术前检查UCG。(证据级别:C;推荐强度:IIa)
[znzldj] => A
[_inputtime] => 1734572560
[_updatetime] => 1734572560
[_nrjc] =>
[_nrsh] =>
)
推荐意见
新发现杂音、但没有其他CVD症状或体征的患者,推荐在中高风险NCS术前检查UCG。(证据级别:C;推荐强度:IIa)
In patients with a newly detected murmur, but without other signs or symptoms of CVD, TTE should be considered before moderate-risk NCS.(Evidence: Level C,Recommendation: Class IIa)
证据评价方法:LOE
指南质量等级:A
年份:2022
国家:the European Society of Anaesthesiology and Intens
Array
(
[id] => 1896
[catid] => 92
[title] => Perioperative fluid management: evidence-based consensus recommendations from the international multidisciplinary PeriOperative Quality Initiative
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1896.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:23:27
[updatetime] => 2024-12-12 11:23:27
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39341776/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => /
[pdf] =>
[tjyjyw] =>
[lyyw] => We recommend against use of hypotonic solutions in
neurosurgical patients. (Strong recommendation, mod-
erate quality evidence)
[laiyuan] => 在神经外科手术中,不建议使用低渗溶液。(强烈推荐;中等质量证据)
[znzldj] => B级
[_inputtime] => 1733973807
[_updatetime] => 1733973807
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在神经外科手术中,不建议使用低渗溶液。(强烈推荐;中等质量证据)
We recommend against use of hypotonic solutions in
neurosurgical patients. (Strong recommendation, mod-
erate quality evidence)
证据评价方法:GRADE
指南质量等级:B级
年份:2024
国家:/
Array
(
[id] => 1897
[catid] => 92
[title] => Perioperative fluid management: evidence-based consensus recommendations from the international multidisciplinary PeriOperative Quality Initiative
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1897.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:23:27
[updatetime] => 2024-12-12 11:23:27
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39341776/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => /
[pdf] =>
[tjyjyw] =>
[lyyw] => We recommend use of 0.9% saline as a first-line fluid
therapy in patients with traumatic brain injury. (Weak
recommendation, moderate quality evidence)
[laiyuan] => 在神经外科手术中,建议将0.9%生理盐水作为创伤性脑损伤患者的一线液体治疗。(弱推荐;中等质量证据)
[znzldj] => B级
[_inputtime] => 1733973807
[_updatetime] => 1733973807
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在神经外科手术中,建议将0.9%生理盐水作为创伤性脑损伤患者的一线液体治疗。(弱推荐;中等质量证据)
We recommend use of 0.9% saline as a first-line fluid
therapy in patients with traumatic brain injury. (Weak
recommendation, moderate quality evidence)
证据评价方法:GRADE
指南质量等级:B级
年份:2024
国家:/
Array
(
[id] => 1898
[catid] => 92
[title] => Perioperative fluid management: evidence-based consensus recommendations from the international multidisciplinary PeriOperative Quality Initiative
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1898.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:23:27
[updatetime] => 2024-12-12 11:23:27
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39341776/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => /
[pdf] =>
[tjyjyw] =>
[lyyw] => We recommend against use of albumin in patients with
traumatic brain injury. (Strong recommendation, moder-
ate quality evidence)
[laiyuan] => 在神经外科手术中,不建议对创伤性脑损伤患者使用白蛋白。(强烈推荐;中等质量证据)
[znzldj] => B级
[_inputtime] => 1733973807
[_updatetime] => 1733973807
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在神经外科手术中,不建议对创伤性脑损伤患者使用白蛋白。(强烈推荐;中等质量证据)
We recommend against use of albumin in patients with
traumatic brain injury. (Strong recommendation, moder-
ate quality evidence)
证据评价方法:GRADE
指南质量等级:B级
年份:2024
国家:/
Array
(
[id] => 1899
[catid] => 197
[title] => Perioperative fluid management: evidence-based consensus recommendations from the international multidisciplinary PeriOperative Quality Initiative
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1899.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:23:27
[updatetime] => 2024-12-12 11:23:27
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39341776/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => /
[pdf] =>
[tjyjyw] =>
[lyyw] => We recommend a mildly positive fluid balance to reduce
the incidence of postoperative nausea and vomiting in
minor noncardiac surgery. (Weak recommendation, low-
quality evidence)
[laiyuan] => 建议在非心脏小型手术中液体轻度正平衡,以减少术后恶心和呕吐的发生率。(弱推荐;低质量证据)
[znzldj] => B级
[_inputtime] => 1733973807
[_updatetime] => 1733973807
[_nrjc] =>
[_nrsh] =>
)
推荐意见
建议在非心脏小型手术中液体轻度正平衡,以减少术后恶心和呕吐的发生率。(弱推荐;低质量证据)
We recommend a mildly positive fluid balance to reduce
the incidence of postoperative nausea and vomiting in
minor noncardiac surgery. (Weak recommendation, low-
quality evidence)
证据评价方法:GRADE
指南质量等级:B级
年份:2024
国家:/
Array
(
[id] => 1900
[catid] => 296
[title] => Perioperative fluid management: evidence-based consensus recommendations from the international multidisciplinary PeriOperative Quality Initiative
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1900.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:23:27
[updatetime] => 2024-12-12 11:23:27
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39341776/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => /
[pdf] =>
[tjyjyw] =>
[lyyw] => We recommend use of buffered crystalloid solutions in
the absence of hypochloraemia. (Strong recommendation,
high-quality evidence)
[laiyuan] => 在危重症患者中,建议在没有低氯血症的情况下使用缓冲晶体溶液。(强烈推荐;高质量证据)
[znzldj] => B级
[_inputtime] => 1733973807
[_updatetime] => 1733973807
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在危重症患者中,建议在没有低氯血症的情况下使用缓冲晶体溶液。(强烈推荐;高质量证据)
We recommend use of buffered crystalloid solutions in
the absence of hypochloraemia. (Strong recommendation,
high-quality evidence)
证据评价方法:GRADE
指南质量等级:B级
年份:2024
国家:/